These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34596727)

  • 1. Effect of gene polymorphism on bleeding complications in Chinese Han patients taking warfarin.
    Xia X; Fu J; Wu T; Chen W; Jiang S; Lv M; Zhang J
    Eur J Clin Pharmacol; 2022 Feb; 78(2):205-214. PubMed ID: 34596727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between apolipoprotein E genotype and warfarin response during initial anticoagulation.
    He S; Zhang H; Cao Y; Nian F; Chen H; Chen W; Auchoybur ML; Yin L; Tao Z; Tang S; Chen X
    Biomed Pharmacother; 2018 May; 101():251-256. PubMed ID: 29494962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To establish a model for the prediction of initial standard and maintenance doses of warfarin for the Han Chinese population based on gene polymorphism: a multicenter study.
    Xia X; Huang N; Li B; Li Y; Zou L; Yuan D; Huang B; Bei Y; Liu Y; Fu J; Wu T; Chen W; Jiang S; Lv M; Zhang J
    Eur J Clin Pharmacol; 2022 Jan; 78(1):43-51. PubMed ID: 34453556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of warfarin dose-associated genotypes on the risk of hemorrhagic complications in Chinese patients on warfarin.
    Ma C; Zhang Y; Xu Q; Yang J; Zhang Y; Gao L; Xu B; Wang H; Li Y; Lu C; Yin T
    Int J Hematol; 2012 Dec; 96(6):719-28. PubMed ID: 23104259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of gene polymorphisms with the risk of warfarin bleeding complications at therapeutic INR in patients with mechanical cardiac valves.
    An SH; Lee KE; Chang BC; Gwak HS
    J Clin Pharm Ther; 2014 Jun; 39(3):314-8. PubMed ID: 24602049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of apolipoprotein E (APOE) polymorphisms with warfarin maintenance dose in a northern Han Chinese population.
    Liu R; Zhang K; Gong ZZ; Shi XM; Zhang Q; Pan XD; Dong R
    Lipids Health Dis; 2016 Feb; 15():34. PubMed ID: 26912074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of
    Li W; Zhao P; Chen L; Lai X; Shi G; Li L; Dong J
    Pharmacogenomics; 2020 Jan; 21(2):101-110. PubMed ID: 31854268
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene polymorphisms and the risk of warfarin-induced bleeding complications at therapeutic international normalized ratio (INR).
    Pourgholi L; Goodarzynejad H; Mandegary A; Ziaee S; Talasaz AH; Jalali A; Boroumand M
    Toxicol Appl Pharmacol; 2016 Oct; 309():37-43. PubMed ID: 27581200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of VKORC1, CYP4F2 and NQO1 gene variants on warfarin dose requirement in Han Chinese patients with catheter ablation for atrial fibrillation.
    Li J; Yang W; Xie Z; Yu K; Chen Y; Cui K
    BMC Cardiovasc Disord; 2018 May; 18(1):96. PubMed ID: 29776386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of CYP2C9*3, VKORC1-1639, CYP4F2rs2108622 genetic polymorphism and clinical factors on warfarin maintenance dose in Han-Chinese patients.
    Liang R; Li L; Li C; Gao Y; Liu W; Hu D; Sun Y
    J Thromb Thrombolysis; 2012 Jul; 34(1):120-5. PubMed ID: 22528326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement.
    Cen HJ; Zeng WT; Leng XY; Huang M; Chen X; Li JL; Huang ZY; Bi HC; Wang XD; He YL; He F; Zhou RN; Zheng QS; Zhao LZ
    Br J Clin Pharmacol; 2010 Aug; 70(2):234-40. PubMed ID: 20653676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Magnitude of the Warfarin-Amiodarone Drug-Drug Interaction Varies With Renal Function: A Propensity-Matched Cohort Study.
    Miano TA; Yang W; Shashaty MGS; Zuppa A; Brown JR; Hennessy S
    Clin Pharmacol Ther; 2020 Jun; 107(6):1446-1456. PubMed ID: 32112562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Polymorphisms in Myc-Related Genes on Bleeding Complications in Patients with Stable Warfarin Responses.
    Yee J; Kim W; Chang BC; Chung JE; Lee KE; Gwak HS
    Cardiovasc Ther; 2019; 2019():1813747. PubMed ID: 31772606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemorrhagic complications of anticoagulant therapy in Chinese patients.
    Chan TY; Miu KY
    J Chin Med Assoc; 2004 Feb; 67(2):55-62. PubMed ID: 15146899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Genetic Variants With Warfarin-Associated Bleeding Among Patients of African Descent.
    De T; Alarcon C; Hernandez W; Liko I; Cavallari LH; Duarte JD; Perera MA
    JAMA; 2018 Oct; 320(16):1670-1677. PubMed ID: 30357299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of warfarin maintenance dose in Han Chinese patients using a mechanistic model based on genetic and non-genetic factors.
    Lu Y; Yang J; Zhang H; Yang J
    Clin Pharmacokinet; 2013 Jul; 52(7):567-81. PubMed ID: 23515956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in VKORC1 have more impact than CYP2C9 polymorphisms on early warfarin International Normalized Ratio control and bleeding rates.
    Lund K; Gaffney D; Spooner R; Etherington AM; Tansey P; Tait RC
    Br J Haematol; 2012 Jul; 158(2):256-261. PubMed ID: 22571356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment with warfarin in Chinese population.
    Chenhsu RY; Chiang SC; Chou MH; Lin MF
    Ann Pharmacother; 2000 Dec; 34(12):1395-401. PubMed ID: 11144695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of warfarin therapy managed by pharmacists via hospital anticoagulation clinic versus online anticoagulation clinic.
    Cao H; Wu J; Zhang J
    Int J Clin Pharm; 2018 Oct; 40(5):1072-1077. PubMed ID: 29956134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Establishment and preliminary validation of warfarin maintenance dose algorithm in Chinese Han Population].
    Lou Y; Hua L; Han L; Li Y; Zhang X; Tang M; Yu H; Liu Z; Wang W; Xu J; Liu H; Li Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 May; 42(5):384-8. PubMed ID: 25042915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.